IMMUNESENSOR THERAPEUTICS
ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other autoimmune diseases. Dedicated to developing new medicines that use the body's innate immune system to cure a variety of diseases.
IMMUNESENSOR THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2019-01-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.immunesensor.com
Total Employee:
1+
Status:
Active
Contact:
+1 469 757 5110
Email Addresses:
[email protected]
Similar Organizations
AcureX Therapeutics
AcureX Therapeutics is a biotechnology company.
Geneius
Geneius is a Biotechnology company.
Rekindle Therapeutics
Rekindle Therapeutics is a biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.immunesensor.com
- Host name: ec2-34-192-255-123.compute-1.amazonaws.com
- IP address: 34.192.255.123
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "ImmuneSensor Therapeutics"
About Us | ImmuneSensor Therapeutics
Our History Pioneers of cGAS/cGAMP. ImmuneSensor was founded in 2014 based on the seminal research conducted in the laboratory of Dr. Zhijian “James” Chen's at the University of …See details»
ImmuneSensor Therapeutics | IMSA101 | cGAS-STING …
ImmuneSensor Therapeutics is a clinical-stage biotechnology company focused on developing novel medicines that target the cGAS-STING pathway to modulate the innate immune system. Based on groundbreaking discoveries from the …See details»
ImmuneSensor Therapeutics - Crunchbase Company …
ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other autoimmune diseases. It is …See details»
IMMUNE SENSOR, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IMMUNE SENSOR, LLC of Dallas, TX. Get the latest business insights from Dun & Bradstreet.See details»
IMMUNESENSOR THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IMMUNESENSOR THERAPEUTICS, INC. of Dallas, TX. Get the latest business insights from …See details»
ImmuneSensor Therapeutics Company Profile - Office Locations
ImmuneSensor Therapeutics is a company aiming to treat cancer and autoimmune diseases. It develops medicines that target the cGAS (cyclic GMP-AMP synthase) – STING (stimulator of …See details»
ImmuneSensor Therapeutics, Inc. - Drug pipelines, Patents
Explore ImmuneSensor Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 8 news, Disease Domain:Neoplasms, Nervous System Diseases, …See details»
ImmuneSensor Therapeutics - VentureRadar
" ImmuneSensor Therapeutics is developing novel medicines that target the cGAS (cyclic GMP-AMP synthase) – STING (stimulator of interferon genes) pathway to modulate the innate …See details»
Press Release Distribution and Management - GlobeNewswire
DALLAS, Sept. 16, 2024 (GLOBE NEWSWIRE) -- ImmuneSensor Therapeutics, a clinical-stage biotherapeutics company focused on the development of first- and best-in-class inhibitors and …See details»
ImmuneSensor - Products, Competitors, Financials, Employees ...
ImmuneSensor is a clinical-stage biotechnology company focused on developing novel medicines within the healthcare sector. The company's main offerings include STING activators for …See details»
ImmuneSensor Therapeutics - Funding, Financials, Valuation
ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other diseases. New. Resources. Advanced Search. ... How much …See details»
ImmuneSensor Therapeutics - Contacts, Employees, Board …
ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other diseases. ... Experience the new Crunchbase, powered by AI . …See details»
Immunesensor Therapeutics Inc. - BioCentury Company Profiles
May 1, 2024 Immunesensor Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Press Release | ImmuneSensor Therapeutics
Nov 20, 2024 ImmuneSensor is developing IMSB301 initially in cGAS-driven Type I interferonopathies including AGS, as well as CLE and selected patient populations with SLE. …See details»
IMSA-101 by ImmuneSensor Therapeutics for Hematological …
Jan 20, 2025 ImmuneSensor Therapeutics overview. ImmuneSensor Therapeutics is a clinical stage biopharmaceutical company that develops novel treatments that address both cancers …See details»
ImmuneSensor Therapeutics Announces New President/CEO
May 3, 2024 ImmuneSensor said its lead clinical asset, IMSA101, is a novel small molecule STING agonist designed with a unique “defense-sensing” mechanism that increases antitumor …See details»
ImmuneSensor Therapeutics Initiates Dosing in Phase 1
Oct 8, 2024 ImmuneSensor is a privately held, clinical stage company founded on the groundbreaking discovery of cGAS and cGAMP along with their combined role in regulating …See details»
ImmuneSensor Therapeutics Initiates Dosing in Phase 1 Trial of …
ImmuneSensor is a privately held, clinical-stage company founded on the groundbreaking discovery of cGAS and cGAMP along with their combined role in regulating immunity, by Dr. …See details»
ImmuneSensor Therapeutics Receives Orphan Drug and Rare
Nov 20, 2024 ImmuneSensor is a privately held, clinical stage company founded on the groundbreaking discovery of cGAS and cGAMP along with their combined role in regulating …See details»
IMSA-101 by ImmuneSensor Therapeutics for Head And Neck …
ImmuneSensor Therapeutics overview. ImmuneSensor Therapeutics is a clinical stage biopharmaceutical company that develops novel treatments that address both cancers and …See details»